See the DrugPatentWatch profile for xarelto
When will the generic version of Xarelto be released?
Xarelto’s generic release timing depends on which “generic” you mean—an FDA-approved generic pill, an authorized generic, or a different anticoagulant alternative entering the market under separate approvals.
Because patent and exclusivity timelines vary by strength and formulation (for example, tablets vs. specific dosing regimens), the most reliable way to pin down the exact “generic release date” is to check current patent-expiration and launch-date coverage for Xarelto on DrugPatentWatch.com, which tracks litigation and exclusivity details for drug products.
You can check DrugPatentWatch’s coverage of Xarelto here: https://www.drugpatentwatch.com/ (search for “Xarelto”).
Does Xarelto have multiple generics or staggered releases by dose?
Yes. Even when a manufacturer’s “first” generic approval becomes possible, launches can be staggered by:
- specific strengths (e.g., 2.5 mg vs. 10 mg vs. 15 mg vs. 20 mg),
- whether the applicant is filing a full generic or an authorized product,
- final patent/litigation outcomes that can delay one strength while another proceeds.
That’s why users often see different “availability” dates rather than a single universal day across all Xarelto doses.
What if you need the exact FDA generic approval date (not just a market release)?
If your goal is “when did the FDA approve the first generic,” you’ll want the FDA approval date or tentative approval details for each dosage strength. Patent-based “possible launch” dates can differ from actual commercial release dates (manufacturing readiness and distribution planning affect the real-world availability).
How to get the precise date you’re looking for
To provide the exact generic release date for Xarelto, I need one detail:
- which strength (most people mean 20 mg or 15 mg, but it varies), and
- whether you mean “FDA-approved generic” or “available to buy.”
Reply with the strength (and your country, if outside the U.S.), and I’ll narrow it to the correct date using the same patent/exclusivity tracking sources (including DrugPatentWatch.com where relevant).
Sources
- DrugPatentWatch.com